PTC Therapeutics Inc (PTCT) Company Profile & Statistics

PTC Therapeutics Inc
PTCT
(Nasdaq - US)
Closed
44.37
+1.41 (+3.28%)
in:usd•As of: Nov 08, 2024 15:59 UTC -5
Open
45.00
High
46.48
Low
43.76

About PTC Therapeutics Inc

CEO

Mathew B. Klein

Headquarters

100 corporate court

south plainfield, nj 07080, united states

Auditor

Ernst & Young LLP

Employees

995

Share Holders

Website

www.ptcbio.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

PTC Therapeutics, Inc. is a biopharmaceutical company. It is focused on the discovery and development of orally administered, small-molecule drugs for genetic disorders, oncology and infectious disease. PTC Therapeutics, Inc. is based in South Plainfield, United States.

PTC Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	3.41B
Enterprise Value	5.15B
Enterprise Value/EBITDA (ttm)	-10.63K
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	3.69
Price to Cash (ytd)	17.82

Profitability

Gross Margin (ttm)	92.59%
Operating Margin (ttm)	-36.90%
Profit Margin (ttm)	-53.77%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-54.79%
Return on Assets (ttm)	-19.37%

Income Statement

Revenue (ttm)	900.45M
Revenue Per Share (ttm)	11.71
Gross Profit (ttm)	831.58M
EBITDA (ttm)³	-484.10K
Net Income Avi to Common (ttm)	-479.52M
Diluted EPS (ttm)	-6.31

Share Statistics

Beta (5Y Monthly)	0.63
52-Week Change	126.38%
S&P500 52-Week Change	36.80%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	76.92M
Dividend Yield	0.00%
Float ⁴	72.69M
% Held by Insiders	5.50%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	1.09B
Total Cash Per Share (mrq)	14.21
Total Debt (mrq)	2.39B
Total Debt/Equity (mrq)	-243.58%
Current Ratio (mrq)	2.23%
Quick Ratio (mrq)	2.17%
Book Value Per Share (mrq)	-12.75

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.01
Free Cash Flow (ytd)	25.13M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PTC Therapeutics Inc

Trade With A Regulated Broker